AI can help make healthcare more accessible, personalised & inclusive. In my message at the @Europarl_EN event hosted by @AntonellaSberna, @FiocchiPietro & @ChiaraGemmaUE, I explain how 🇪🇺innovation can serve people with disabilities &patients across Europe. Watch below 🎦⬇️ https://t.co/vmIauARWny #HealthcareInnovation #Accessibility #Inclusion #EU
@GaoShanghua @ayushnoori @CurtGinder @BenGlicksberg @RanBalicer @HarvardDBMI @KempnerInst @biohub @IcahnMountSinai @ClalitHealth @BrighamWomens 🟢 Benchmarking: Across 3,168 drug reasoning questions (DrugPC) and 456 patient specific treatment cases (TreatmentPC), ATHENA hit 94.7% and 82.9% accuracy, beating GPT-5 by 17.8 and 10.7 points and DeepSeek-R1 (671B) by even more. What stood out: giving GPT-5 optional tool https://t.co/xdmOHeiS8U #AI #DrugDevelopment #HealthcareInnovation #Nospecificcountriesarementionedinthetweet.
During a guided tour with MMCI Director Marek Svoboda, I saw the state-of-the-art facilities of the new Cancer Prevention Centre in Brno 🇨🇿 With technologies from photon CT and MRI to AI-supported whole-body skin scanning, the Centre can become a model for others in 🇪🇺 to follow. https://t.co/He0Wsj8ZYE #CancerPrevention #Brno #HealthcareInnovation #CZ #EU
A patient expressed her relief at Ipswich Hospital's trial of a new, less invasive womb cancer test called WID-easy, which resembles a smear test and offers quicker results, highlighting a positive shift in how women's health issues are addressed. #WomensHealth #CancerAwareness #HealthcareInnovation #GB
A patient expressed her relief and confidence in women's health care after Ipswich Hospital began trialing the less invasive WID-easy test for womb cancer, which provides faster results and minimizes the discomfort traditionally associated with such procedures. #WomensHealth #CancerAwareness #HealthcareInnovation #GB
A patient expressed her relief and satisfaction with Ipswich Hospital's introduction of the WID-easy test for womb cancer, describing it as a less invasive and quicker alternative to traditional procedures, which she believes demonstrates a genuine commitment to women's health. #WomensHealth #CancerAwareness #HealthcareInnovation #GB
Recent research by Scottish Women's Aid reveals that women are increasingly turning to loan sharks due to economic abuse from partners who coerce them into debt, highlighting the hidden dangers of coerced financial control. #WomenEmpowerment #EconomicAbuse #HealthcareInnovation #GB #US #CN
RT @skiistiredasf: Dr. Iman Abuzeid, a Sudanese-American physician, founded Incredible Health — a platform that flips traditional hiring by… #IncredibleHealth #HealthcareInnovation #MedicalTech #SD #US
The Trump administration has launched a test program to provide free CBD to thousands of Medicare patients, aiming to assess its potential benefits in improving quality of life and reducing healthcare costs among older adults, despite concerns from some healthcare professionals about safety and the need for further research. #CBD #HealthcareInnovation #AgingPopulation #US #FL #NY #OK #TX #WI #WV #AZ #KY
The newly opened £48 million Wound Innovation Institute in Hull aims to revolutionize treatment for chronic wounds by uniting researchers, NHS clinicians, and industry partners to develop innovative therapies, addressing a critical clinical need that costs the NHS £8.3 billion annually. #WoundCare #MedicalResearch #HealthcareInnovation #GB
The newly established £48 million Wound Innovation Institute in Hull aims to revolutionize the treatment of chronic wounds by collaborating with academics, NHS clinicians, and industry partners to research their causes and develop innovative therapies, with significant funding support from both private companies and government grants. #WoundCare #MedicalResearch #HealthcareInnovation #GB
The Wound Innovation Institute at the University of Hull, supported by £48m in funding, aims to revolutionize the treatment of chronic wounds through research collaborations that promise to significantly improve patient outcomes and reduce NHS costs. #WoundCare #MedicalResearch #HealthcareInnovation #GB
The newly opened £48m Wound Innovation Institute in Hull aims to transform the treatment of chronic wounds by collaborating with academics, NHS clinicians, and industry partners to develop innovative therapies and advance research in the field, addressing a significant area of unmet clinical need. #WoundCare #MedicalResearch #HealthcareInnovation #GB
The newly opened £48m Wound Innovation Institute in Hull aims to transform the treatment of chronic wounds by collaborating with academics, NHS clinicians, and industry partners to develop innovative therapies and advance research in the field, addressing a significant area of unmet clinical need. #WoundCare #MedicalResearch #HealthcareInnovation #GB
A nine-year-old boy's life has been "fundamentally changed" thanks to approved treatments for spinal muscular atrophy (SMA), allowing him to reach significant milestones like starting mainstream school despite a grim prognosis. #SMA #RareDiseases #HealthcareInnovation #GB
Cooperation with key partners, including the United States, remains essential to tackling shared global health challenges and supporting stability and prosperity. A strong, competitive European healthcare ecosystem is key to this effort. Read more ⬇️ https://t.co/g95j3OReRi #GlobalHealth #HealthcareInnovation #InternationalCooperation #US #EU
RT @skiistiredasf: Kimberly Barrow, MSN, APRN, NP-C, a dedicated Black Family Nurse Practitioner, launched Kimberly Cares clinic in Housto… #NursePractitioner #HealthcareInnovation #CommunityCare #US
Roche announced that Elecsys pTau217, the first blood test designed to signal and rule out Alzheimer's disease, has received CE Mark clearance for use in Europe, offering a faster and simpler diagnostic tool for millions of patients and potentially reducing the burden on healthcare systems. #Alzheimers #BloodTest #HealthcareInnovation #EU #CH #US
Roche announced that Elecsys pTau217, the first blood test specifically designed to signal and rule out Alzheimer's disease, has received CE Mark approval for use in Europe, promising faster diagnoses for millions of patients by detecting pTau217 protein levels, thereby indicating the likelihood of Alzheimer's while potentially reducing the need for more invasive testing. #AlzheimersDisease #Diagnostics #HealthcareInnovation #EU #CH
Roche has received clearance for Elecsys pTau217, the first blood test designed to diagnose and rule out Alzheimer's disease in Europe, which promises faster diagnoses for millions of patients by detecting levels of a protein linked to the disease. #AlzheimersDisease #BloodTest #HealthcareInnovation #EU #CH #US
